摘要
背景:轻度帕金森综合征(MPS)多见于老年,与脑小血管疾病(SVD)有关,且无单一结果。 目的:探讨大脑中基质金属蛋白酶(MPS)与脑白质高信号(WMH)、腔隙、尾状萎缩和全脑萎缩的横断面关系。 神经系统和认知健康(NCH)的老年人。 方法:对1,219例NCH患者进行常规脑MRI检查。采用统一帕金森病评定量表中的运动部分项目对Trem进行评定。 或者,僵硬,运动迟缓,步态/平衡/轴功能障碍。对尾状萎缩和全脑萎缩分别用双听率和侧脑室脑比进行评估。 很有趣。采用两种视觉评分量表对WMH进行评定。空白也被评定。MPS与血管危险因素/疾病及影像学表现的相关性是通过Logistic再灌注来确定的。 回归分析。 结果:额叶、基底节区腔隙、额叶WMH、尾状萎缩、全脑萎缩与运动迟缓有关。基底节腔隙、尾状萎缩和全脑ATR POY与步态/平衡/轴向功能障碍有关。强直与额叶WMH有关,震颤伴尾状萎缩和全脑萎缩。使用MPS的受试者,表现较少。 在评估全球认知和语言的测试中,没有MPS的汉族受试者。 结论:本研究表明,在NCH衰老个体中,MPS与皮层和皮质下血管及萎缩有关,可能是早期认知的警告信号。 我谢绝了。MPS患者应严格管理大脑SVD,以防止未来的身体和认知障碍。
关键词: 健康老年人,轻度帕金森病征,白质高信号,腔隙,尾状核萎缩,全脑萎缩。
Current Alzheimer Research
Title:Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study
Volume: 15 Issue: 11
关键词: 健康老年人,轻度帕金森病征,白质高信号,腔隙,尾状核萎缩,全脑萎缩。
摘要: Background: Mild Parkinsonian signs (MPS) are commonly seen in aging, and have been related to cerebral Small Vessel Diseases (SVD) with no univocal results.
Objective: The aim of this study was to investigate the cross-sectional relation between MPS and White Matter Hyperintensities (WMH), lacunes, caudate atrophy, and global cerebral atrophy in a large cohort of Neurologically and Cognitively Healthy (NCH) aging individuals.
Method: 1,219 NCH individuals were included in the analysis, and underwent standard brain MRI. The items of the motor section of the Unified Parkinson’s Disease Rating Scale were used to evaluate tremor, rigidity, bradykinesia, and gait/balance/axial dysfunction. Caudate atrophy and global cerebral atrophy were assessed through the bicaudate ratio and the lateral ventricles to brain ratio, respectively. WMH were assessed through two visual rating scales. Lacunes were also rated. Associations of MPS with vascular risk factors/diseases and imaging findings were determined through the logistic regression analysis.
Results: Frontal and basal ganglia lacunes, frontal WMH, caudate atrophy, and global cerebral atrophy were associated with bradykinesia. Basal ganglia lacunes, caudate atrophy, and global cerebral atrophy were associated with gait/balance/axial dysfunction. Rigidity was associated with frontal WMH, and tremor with caudate atrophy and global cerebral atrophy. NCH subjects with MPS, performed less than subjects without MPS in tests evaluating global cognition and language.
Conclusion: This study demonstrates that in NCH aging individuals, MPS are associated with cortical and subcortical vascular and atrophic changes, and are probably, a warning sign of incipient cognitive decline. Subjects with MPS should manage rigorously cerebral SVD to prevent future physical and cognitive disabilities.
Export Options
About this article
Cite this article as:
Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study, Current Alzheimer Research 2018; 15 (11) . https://dx.doi.org/10.2174/1567205015666180702111110
DOI https://dx.doi.org/10.2174/1567205015666180702111110 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Assessing Schizophrenia-relevant Cognitive and Social Deficits in Mice: A Selection of Mouse Behavioral Tasks and Potential Therapeutic Compounds
Current Pharmaceutical Design Nanomedicinal Approach of Getting Across the Brood-Brain Barrier with Nanomedicinal Nanoparticles
Current Medicinal Chemistry Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry An Update on GABAρ Receptors
Current Neuropharmacology Heteromerization of G Protein-Coupled Receptors: Relevance to Neurological Disorders and Neurotherapeutics
CNS & Neurological Disorders - Drug Targets Diagnostic and Pathophysiological Impact of FP-CIT SPECT in Parkinson s Disease
Central Nervous System Agents in Medicinal Chemistry Neural Stem Cell Niches in Health and Diseases
Current Pharmaceutical Design Substance P Regulation in Epilepsy
Current Neuropharmacology Moving Beyond Tyrosine Hydroxylase to Define Dopaminergic Neurons for Use in Cell Replacement Therapies for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach
Current Pharmaceutical Design Lower K<sub>V</sub>7.5 Potassium Channel Subunit Expression in an Animal Model of Paroxysmal Dystonia
CNS & Neurological Disorders - Drug Targets Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment
Current Pharmaceutical Design Serotonin (5-HT) in the Regulation of Depression-Related Emotionality: Insight from 5-HT Transporter and Tryptophan Hydroxylase-2 Knockout Mouse Models
Current Drug Targets Animal Models for Investigating Benign Essential Blepharospasm
Current Neuropharmacology TRPV1: On the Road to Pain Relief
Current Molecular Pharmacology New Therapeutic Strategy for Parkinson’s and Alzheimer’s Disease
Current Medicinal Chemistry Editorial (Thematic Issue: Novel Perspectives for Parkinson’s Disease Therapy: Insights from the Latest Advances in Disease Pathophysiology, Diagnostic and Experimental Tools and Molecular Targets)
CNS & Neurological Disorders - Drug Targets Benzopentathiepine Derivative, 8-(Trifluoromethyl)-1,2,3,4,5-Benzopentathiepin- 6-Amine Hydrochloride (TC-2153), as a Promising Antidepressant of New Generation
Letters in Drug Design & Discovery Editorial (Thematic Issue: Cocaine and Amphetamine-Type Stimulants: the Search for Pharmacological Therapies)
Current Pharmaceutical Design Striatal-enriched Tyrosine Protein Phosphatase (STEP) in the Mechanisms of Depressive Disorders
Current Protein & Peptide Science